Conductors of the Immune System
Myeloid cells are the front lines of defense against disease, responsible for choreographing downstream immune responses. They’re also versatile, with effector functions capable of killing cancer cells. When applied to a therapeutic candidate, immunotherapy is designed to recognize and engulf cancer cells, produce anti-tumor agents, promote anti-tumor adaptive immunity, alter the tumor microenvironment, and ultimately kill cancer.
Our therapies incorporate advanced cell and gene therapy methods, combining immunology, genetics, cell biology, and protein science to improve the lives of patients in need.
In Vivo mRNA Programming
mRNA Cell Therapy
Our capabilities translate into unmatched product designs with transformative “full-immune” engagement.